Horne; Stephen E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Horne; Stephen E..The latest application filed is for "processes for the preparation of chiral beta amino acid derivatives using asymmetric hydrogenation catalysts".

Company Profile

0.15.17

Horne; Stephen E. - Burlington CA
Horne; Stephen E. - Brantford CA
HORNE, STEPHEN E - BURLINGTON CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Processes for the Preparation of Chiral Beta Amino Acid Derivatives Using Asymmetric Hydrogenation Catalysts App 20150353564 - Abdur-Rashid; Kamaluddin ; et al.	2015-12-10
Process for the preparation of esomeprazole and salts thereof Grant 8,563,733 - Wang , et al. October 22, 2	2013-10-22
Preparation of acid addition salts of amine bases by solid phase--gas phase reactions Grant 8,471,011 - Rey , et al. June 25, 2	2013-06-25
Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3')quiniclidine hydrochloride Grant 8,143,400 - Bratovanov , et al. March 27, 2	2012-03-27
Process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3')quiniclidine Grant 8,080,663 - Bratovanov , et al. December 20, 2	2011-12-20
Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihy- dro-2H-indol-2-one hydrochloride) and processes to produce the same Grant 7,939,662 - Zetina-Rocha , et al. May 10, 2	2011-05-10
Preparation Of Oseltamivir Phosphate (tamiflu.rtm.) And Intermediates Starting From D-glucose Or D-xylose App 20110040120 - RADATUS; Bruno Konrad ; et al.	2011-02-17
Novel Process for the Preparation of Esomeprazole and Salts Thereof App 20100324298 - Wang; Fan ; et al.	2010-12-23
Process for the preparation and purification of eplerenone Grant 7,851,619 - Bejan , et al. December 14, 2	2010-12-14
Process for the preparation of esomeprazole and salts thereof Grant 7,786,309 - Wang , et al. August 31, 2	2010-08-31
Process for the preparation of phenylcarbamates Grant 7,767,843 - Wang , et al. August 3, 2	2010-08-03
Process for producing atorvastatin hemicalcium Grant 7,615,647 - Murthy , et al. November 10, 2	2009-11-10
Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3')quiniclidine hydrochloride App 20090182146 - Bratovanov; Svetoslav S. ; et al.	2009-07-16
Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihy- dro-2H-indol-2-one hydrochloride) and processes to produce the same App 20090030204 - Zetina-Rocha; Carlos ; et al.	2009-01-29
Process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3')quiniclidine App 20080249312 - Bratovanov; Svetoslav S. ; et al.	2008-10-09
Process for the preparation and purification of eplerenone App 20080234478 - Guntoori; Bhaskar Reddy ; et al.	2008-09-25
Preparation of oseltamivir phosphate (Tamiflu) and intermediates starting from D-glucose or D-xylose App 20080009639 - Radatus; Bruno Konrad ; et al.	2008-01-10
Process for the Preparation of Ziprasidone (5-[2-[4-(1,2-Benziosothiazol-3-Y1)-1-Piperazinyl]Ethyl]-6-Chloro-1,3-Dih- ydro-2H-Indol-2- One App 20070265447 - Zetina-Rocha; Carlos ; et al.	2007-11-15
Process for the preparation of phenylcarbamates App 20070207990 - Wang; Zhi-Xian ; et al.	2007-09-06
Process for the production of cilostazol App 20070105898 - Li; YuanQiang ; et al.	2007-05-10
Preparation of atorvastatin Grant 7,193,090 - Guntoori , et al. March 20, 2	2007-03-20
Process for producing atorvastatin hemicalcium App 20060199855 - Murthy; K.S. Keshava ; et al.	2006-09-07
Preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihyd- ro-2H-indol-2-one hydrochloride (ziprasidone hydrochloride) Grant 7,087,611 - Zetina-Rocha , et al. August 8, 2	2006-08-08
Process for the preparation of polypeptide 1 Grant 7,049,399 - Bejan , et al. May 23, 2	2006-05-23
Preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-pi- perazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride (ziprasidone hydrochloride) App 20050277651 - Zetina-Rocha, Carlos ; et al.	2005-12-15
Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-p- iperazinyl]ethyl]-6-chloro-1, 3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same App 20050256139 - Zetina-Rocha, Carlos ; et al.	2005-11-17
Preparation of atorvastatin App 20050203302 - Guntoori, Bhaskar Reddy ; et al.	2005-09-15
Process for the preparation of polypeptide 1 App 20040091956 - Bejan, Elena ; et al.	2004-05-13
Preparation of chiral 1,2,3,4-tetrahydro-6,7-dialkoxy-3-isoquinolinecarboxylic acid and derivatives Grant 6,642,384 - Wang , et al. November 4, 2	2003-11-04
Process For Producing Simvastatin App 20010053859 - MURTHY, K. S. KESHAVA ; et al.	2001-12-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.